Envista Holdings Corp
NVSTOther · Large accelerated filer · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $2.72B | $2.51B | $2.57B | $2.57B | $2.51B | $1.93B |
| Operating income | $216.1M | −$1.04B | $31.5M | $319.2M | $306.2M | $43.5M |
| Net income | $47.0M | −$1.12B | −$100.2M | $243.1M | $340.5M | $33.3M |
| Total assets | $5.68B | $5.35B | $6.61B | $6.59B | $6.57B | $6.88B |
| Total liabilities | — | — | — | — | — | — |
| Equity | $3.11B | $2.93B | $4.17B | $4.21B | $4.06B | $3.72B |
| EPS (diluted) | $0.28 | $-6.50 | $-0.60 | $1.37 | $1.92 | $0.20 |
| Shares out. | 172.2M | 171.6M | 163.2M | 161.8M | 160.1M | 158.9M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- 7.9%
- Net margin
- 1.7%
- Return on equity
- 1.5%
- Return on assets
- 0.8%
- Return on capital (ROCE)
- 4.5%
- Liabilities / assets
- —
- Debt / equity
- —
- Book value / share
- $18.04
- Revenue growth (YoY)
- 8.3%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Accruals / assets
- −4.0%clean
- Piotroski F-Score
- 7/8strong
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 4 good- Operating margin is positive
- Revenue is growing year-over-year
- Positive operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Morgan StanleyPassive (13G)May 11, 2026
- Vanguard Capital Management LlcPassive (13G)Apr 29, 2026
- Vanguard Group IncPassive (13G)Mar 26, 2026
- Franklin Mutual Advisers LlcPassive (13G)Jan 29, 2026
- Harris Associates L PPassive (13G)Aug 14, 2025
- Dimensional Fund Advisors LpPassive (13G)Jul 15, 2025
- Blackrock, Inc.Passive (13G)Apr 17, 2025
- American Century Investment Management IncPassive (13G)Feb 14, 2025
- Ariel Investments, LlcPassive (13G)Nov 12, 2024
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Keel Paul AOfficer — Chief Executive Officer | May 25, 2026 | Tax withholding | 12,811 | $23.43 |
| Carruthers WendyDirector | May 19, 2026 | Grant | 9,330 | $0.00 |
| Tsingos Christine ADirector | May 19, 2026 | Grant | 9,330 | $0.00 |
| Jain VivekDirector | May 19, 2026 | Grant | 9,330 | $0.00 |
| Gallahue KieranDirector | May 19, 2026 | Grant | 9,330 | $0.00 |
| Pierce James AndrewDirector | May 19, 2026 | Grant | 9,330 | $0.00 |
| Raskas DanielDirector | May 19, 2026 | Grant | 9,330 | $0.00 |
| Huennekens R ScottDirector | May 19, 2026 | Grant | 12,585 | $0.00 |
| Hammes Eric D.Officer — Chief Financial Officer | Feb 25, 2026 | Tax withholding | 2,045 | $29.59 |
| Acurio VeronicaOfficer — President, Orthodontics | Feb 25, 2026 | Tax withholding | 1,412 | $29.59 |
| Nilsson StefanOfficer — President, Nobel Biocare | Feb 25, 2026 | Tax withholding | 182 | $29.59 |
| Reis MischaOfficer — SVP, Strategy & Bus. Dev. | Feb 25, 2026 | Tax withholding | 2,976 | $29.59 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 11.4M | 2.7 | +20.9% |
| Apr 30, 2026 | 9.4M | 4.0 | -14.3% |
| Apr 15, 2026 | 11.0M | 5.5 | +13.7% |
| Mar 31, 2026 | 9.7M | 4.1 | +32.8% |
| Mar 13, 2026 | 7.3M | 2.9 | -2.9% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Shareholder voteMay 21, 2026
- Results of operations · Regulation FD disclosureMay 6, 2026
- Results of operations · Regulation FD disclosureFeb 5, 2026
- Results of operations · Regulation FD disclosureOct 29, 2025
- Regulation FD disclosureOct 29, 2025
- Director / officer changeSep 17, 2025
- Results of operations · Regulation FD disclosureJul 31, 2025
- Director / officer changeJul 16, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.